Standard Register Establishes Healthcare Center of Excellence in Atlanta

DAYTON, Ohio-- Standard Register (NYSE: SR) announced that it will establish a Healthcare Software and Services Center of Excellence in Atlanta, leveraging its market position to become a leading provider of communication solutions to the healthcare industry. To extend Standard Register Healthcare’s portfolio with innovative technology-enabled solutions that focus on workflow management and effective delivery of content to improve patient care, additional software developers and other healthcare technology specialists will be recruited.

“The future of healthcare depends on empowering people with information – patients, families and healthcare providers across the continuum of care,” said John King, president of the Standard Register Healthcare business unit. “Only by aligning providers and engaging patients to become active participants in managing their care can the industry enhance population health and drive down the cost of healthcare. Standard Register helps our customers standardize and manage the communications that influence behavior and drive desired outcomes. With our strong market presence, we are well positioned to become one of the industry’s leading healthcare communications companies.”

Standard Register Healthcare provides a comprehensive suite of software, services and a world-class, multi-media communication platform to support providers and payers in addressing the wide of array of governmental mandates and their business issues. The business unit serves more than 1,700 hospitals, including 450 technology customers, with digitally delivered patient information. Standard Register’s current portfolio includes services and solutions for standardizing, automating and improving management of informed patient consent, patient access/registration, clinical documentation and patient discharge as well as print-based materials for marketing, staff communications and patient education.

“Standard Register has more than 80 years of leadership and expertise in healthcare,” said Joseph P. Morgan, Jr., president and chief executive officer of Standard Register. “There is tremendous opportunity to shift from a print-centric model to a balanced technology and services model. By designating a Healthcare Software and Services Center of Excellence in Atlanta, we are committing to investing in the further development of technology-enabled solutions that will drive our growth, in the same way that the recently announced Center of Excellence in Jeffersonville, In., is an investment in enhancing our digital printing and distribution leadership. We will leverage our existing intellectual resources and recruit to add to our innovation capabilities.”

About Standard Register

Standard Register (NYSE:SR) is trusted by the world’s leading companies to advance their reputations by aligning communications with corporate standards and priorities. Providing market-specific insights and a compelling portfolio of solutions to address the changing business landscape in healthcare, financial services, commercial and industrial markets, Standard Register is the recognized leader in the management and execution of mission-critical communications. More information is available at http://www.standardregister.com.

Standard Register Healthcare is a business unit of Standard Register, serving more than 1,700 clients from across the healthcare delivery network, including acute, ambulatory, and long-term care, managed care and the suppliers that support them. A recognized leader in managing patient-centric information and communications, Standard Register Healthcare, together with Dialog Medical, a subsidiary of Standard Register, provides services and technology-enabled solutions to standardize and manage communications to improve the coordination of care and achieve desired outcomes. More information is available at www.standardregisterhealthcare.com.

Safe Harbor Statement

This press release contains forward-looking statements covered by the Private Securities Litigation Reform Act of 1995. Because such statements deal with future events, they are subject to various risks and uncertainties and actual results could differ materially from the Company’s current expectations.

Factors that could cause the Company’s results to differ materially from those expressed in forward-looking statements include, without limitation, our access to capital for expanding in our solutions, the pace at which digital technologies and electronic health records (EHR) adoption erode the demand for certain products and services, the success of our plans to deal with the threats and opportunities brought by digital technology, results of cost containment strategies and restructuring programs, our ability to attract and retain key personnel, variation in demand and acceptance of the Company’s products and services, frequency, magnitude and timing of paper and other raw material price changes, the timing of the completion and integration of acquisitions, general business and economic conditions beyond the Company’s control, and the consequences of competitive factors in the marketplace, including the ability to attract and retain customers. The Company undertakes no obligation to revise or update forward-looking statements as a result of new information, since these statements may no longer be accurate or timely. For more information, see the Company’s most recent Form 10-K and other filings with the Securities and Exchange Commission.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.